# Novel Alpha Glucan GI Tolerability Study (Loris Chronic)

> **NCT05142137** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DIETARY_SUPPLEMENT:** Drinkable solution

## Key facts

- **NCT ID:** NCT05142137
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-16
- **Primary completion:** 2021-10-11
- **Final completion:** 2021-10-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05142137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05142137, "Novel Alpha Glucan GI Tolerability Study (Loris Chronic)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05142137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*